Holen Sie sich die Stockscreener-App
1.24
5.08%
0.06
Handel nachbörslich:
1.22
-0.02
-1.61%
Schlusskurs vom Vortag:
$1.18
Offen:
$1.15
24-Stunden-Volumen:
1.39M
Relative Volume:
0.36
Marktkapitalisierung:
$40.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.14M
KGV:
-2.2963
EPS:
-0.54
Netto-Cashflow:
$-3.99M
1W Leistung:
-16.22%
1M Leistung:
-32.24%
6M Leistung:
-69.38%
1J Leistung:
-73.95%
1-Tages-Spanne:
$1.15
$1.3372
1-Wochen-Bereich:
$1.1201
$1.44
52-Wochen-Spanne:
$1.12
$8.40
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Firmenname
Telomir Pharmaceuticals Inc
Sektor
Branche
Telefon
786-396-6723
Adresse
100 SE 2ND ST, MIAMI
Vergleichen Sie TELO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.24 | 38.74M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-21 | Eingeleitet | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten
Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN
Telomir Pharmaceuticals raises $2.9 million through at-the-market stock sale - Investing.com
Real time social sentiment graph for Telomir Pharmaceuticals Inc.Quarterly Profit Review & Proven Capital Preservation Tips - Newser
Earnings visualization tools for Telomir Pharmaceuticals Inc.Portfolio Value Summary & AI Forecasted Stock Moves - Newser
Is Telomir Pharmaceuticals Inc.’s ROE strong enoughRate Cut & Step-by-Step Swing Trade Plans - khodrobank.com
Is Telomir Pharmaceuticals Inc. a speculative investment2025 Technical Overview & Expert Approved Momentum Ideas - khodrobank.com
Using Python tools to backtest Telomir Pharmaceuticals Inc. strategiesJuly 2025 Sentiment & High Accuracy Buy Signal Tips - Newser
Can swing trading help recover from Telomir Pharmaceuticals Inc. lossesIPO Watch & Target Return Focused Picks - Newser
Is Telomir Pharmaceuticals Inc. stock a hidden gemMarket Sentiment Summary & Capital Protection Trade Alerts - khodrobank.com
Using economic indicators to assess Telomir Pharmaceuticals Inc. potentialEarnings Summary Report & Breakout Confirmation Trade Signals - Newser
Is this a good reentry point in Telomir Pharmaceuticals Inc.Weekly Profit Recap & AI Driven Price Predictions - Newser
How to track smart money flows in Telomir Pharmaceuticals Inc.2025 Market Overview & Reliable Volume Spike Alerts - Newser
How hedge fund analytics apply to Telomir Pharmaceuticals Inc. stockBuy Signal & Stock Portfolio Risk Management - Newser
What MACD and RSI say about Telomir Pharmaceuticals Inc.July 2025 Selloffs & Risk Managed Investment Strategies - Newser
Is Telomir Pharmaceuticals Inc. building a consolidation base2025 Top Gainers & Consistent Profit Alerts - Newser
What high frequency data says about Telomir Pharmaceuticals Inc.Inflation Watch & Weekly Stock Breakout Alerts - Newser
Should you avoid Telomir Pharmaceuticals Inc. stock right now2025 Stock Rankings & Risk Managed Investment Signals - khodrobank.com
Using fundamentals and technicals on Telomir Pharmaceuticals Inc.Gap Down & Free High Accuracy Swing Entry Alerts - Newser
Is Telomir Pharmaceuticals Inc. stock entering bullish territoryEarnings Overview Summary & AI Powered Market Trend Analysis - Newser
Is Telomir Pharmaceuticals Inc. forming a bottoming baseGap Down & Weekly High Return Forecasts - Newser
Is now a turning point for Telomir Pharmaceuticals Inc.2025 Price Targets & Free Verified High Yield Trade Plans - Newser
How to forecast Telomir Pharmaceuticals Inc. trends using time series2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
Automated trading signals detected on Telomir Pharmaceuticals Inc.Quarterly Portfolio Report & Real-Time Market Sentiment Reports - Newser
Backtesting results for Telomir Pharmaceuticals Inc. trading strategies2025 Sector Review & Weekly High Conviction Ideas - Newser
Volume spikes in Telomir Pharmaceuticals Inc. stock – what they mean2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
Combining machine learning predictions for Conduit Pharmaceuticals Inc.Weekly Stock Report & Real-Time Sentiment Analysis - Newser
Published on: 2025-09-01 22:17:41 - Newser
Is Telomir Pharmaceuticals Inc. a cyclical or defensive stockEarnings Risk Report & Fast Entry Momentum Trade Alerts - khodrobank.com
Exit Recap: Why is Telomir Pharmaceuticals Inc. stock going downWeekly Risk Summary & Advanced Technical Signal Analysis - khodrobank.com
Statistical indicators supporting Telomir Pharmaceuticals Inc.’s strengthTrade Volume Summary & Real-Time Buy Zone Alerts - Newser
What are Telomir Pharmaceuticals Inc.’s growth leversJuly 2025 Selloffs & Reliable Momentum Entry Alerts - khodrobank.com
How institutional ownership impacts Telomir Pharmaceuticals Inc. stockMarket Volume Summary & Reliable Momentum Entry Alerts - Newser
Will Telomir Pharmaceuticals Inc. stock recover after recent drop2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
What candlestick patterns are forming on Telomir Pharmaceuticals Inc.Market Performance Report & Verified Short-Term Trading Plans - Newser
Will Telomir Pharmaceuticals Inc. outperform the marketMarket Trend Report & Weekly High Conviction Trade Ideas - Newser
What recovery options are there for Telomir Pharmaceuticals Inc.Weekly Investment Summary & Fast Exit and Entry Trade Guides - Newser
Technical analysis overview for Telomir Pharmaceuticals Inc. stock2025 Price Momentum & Weekly High Potential Alerts - Newser
Published on: 2025-08-31 00:41:08 - Newser
Live market analysis of Telomir Pharmaceuticals Inc.July 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):